Recombinant tissue-type plasminogen activator ameliorates ischemic derangements induced by thrombotic occlusion in closed chest anesthetized dogs
- 1 July 1992
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 20 (1) , 218-225
- https://doi.org/10.1016/0735-1097(92)90162-g
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Plasminogen activators. The old and the new.Circulation, 1989
- Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.Circulation, 1987
- Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial.Circulation, 1986
- Coronary thrombolysis and infarct size reduction after intravenous infusion of recombinant tissue-type plasminogen activator in nonhuman primates.Journal of Clinical Investigation, 1985
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.Circulation, 1984
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator.Circulation, 1984
- Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology.Circulation, 1984
- Coronary arterial reperfusion. III. Early and late effects on regional myocardial function and dimensions in conscious dogsThe American Journal of Cardiology, 1976
- Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs.Journal of Clinical Investigation, 1975
- The “No-Reflow” Phenomenon after Temporary Coronary Occlusion in the DogJournal of Clinical Investigation, 1974